Carcinotech
Carcinotech develops Carcino3D technology, which uses 3D printing to create micro-tumors from patient samples. This technology accelerates ethical drug screening and enables the development of more effective, personalized cancer treatments. The company works with global partners, pharma companies, and clinicians to advance oncology drug development.
Buy Funded Startups lists
Funding Round:
Funding Amount: $5.3M
Date: 30-Jan-2024
Investors: Eos Advisory, Investment Fund for Scotland, Maven Capital Partners, Scottish Enterprise, Old College Capital, Investing Women Angels, TRICAPITAL, SIS Ventures, Gabriel Investment Syndicate, Alba Equity
Markets: MedTech, Oncology, Biotechnology
HQ: Edinburgh, Scotland, United Kingdom
Founded: 2018
Website: https://www.carcinotech.co.uk/
LinkedIn: https://uk.linkedin.com/company/carcinotech
Twitter: https://twitter.com/carcinotech
Facebook: https://www.facebook.com/Carcinotech-Ltd-106483164448636
Crunchbase: https://www.crunchbase.com/organization/carcinotech
Leave a Comment
Comments
No comments yet.